Does FOSPHENYTOIN Cause Off label use? 164 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 164 reports of Off label use have been filed in association with FOSPHENYTOIN (CEREBYX). This represents 11.9% of all adverse event reports for FOSPHENYTOIN.
164
Reports of Off label use with FOSPHENYTOIN
11.9%
of all FOSPHENYTOIN reports
18
Deaths
77
Hospitalizations
How Dangerous Is Off label use From FOSPHENYTOIN?
Of the 164 reports, 18 (11.0%) resulted in death, 77 (47.0%) required hospitalization, and 42 (25.6%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for FOSPHENYTOIN. However, 164 reports have been filed with the FAERS database.
What Other Side Effects Does FOSPHENYTOIN Cause?
Drug ineffective (406)
Status epilepticus (82)
Multiple-drug resistance (77)
Cardiac arrest (72)
Seizure (70)
Drug ineffective for unapproved indication (63)
Hypotension (56)
Toxicity to various agents (53)
Bradycardia (39)
Treatment failure (37)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which FOSPHENYTOIN Alternatives Have Lower Off label use Risk?
FOSPHENYTOIN vs FOSTAMATINIB
FOSPHENYTOIN vs FOSTEMSAVIR TROMETHAMINE
FOSPHENYTOIN vs FOTEMUSTINE
FOSPHENYTOIN vs FRAMYCETIN
FOSPHENYTOIN vs FREMANEZUMAB